Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Patients share their stories: groundbreaking study captures Real-Life impact of blood disorder

NCT ID NCT07008820

Summary

This study aims to understand how low-risk myelodysplastic syndrome (MDS) affects patients' daily lives in Japan. Researchers will survey and interview 50 adults with this blood disorder or unexplained anemia to learn about their symptoms, quality of life, and healthcare experiences. The study does not test any treatments but focuses on gathering patient perspectives to improve future care.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME (MDS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Mebix. Inc

    RECRUITING

    Minato-ku, Tokyo, 1050001, Japan

    Contact

Conditions

Explore the condition pages connected to this study.